Caricamento...
Update on reslizumab for eosinophilic asthma
INTRODUCTION: Patients with severe eosinophilic asthma have an unmet need for novel and efficacious treatments. Reslizumab is one of three monoclonal antibodies targeting the interleukin-5 (IL5) pathway and has been found in phase 3b clinical trials to reduce asthma exacerbations, control asthma-rel...
Salvato in:
| Pubblicato in: | Expert Opin Biol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161345/ https://ncbi.nlm.nih.gov/pubmed/26372797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1090972 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|